{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:25:26Z","timestamp":1793931926043,"version":"4.8.0"},"reference-count":181,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2020,3,16]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Praziquantel (PZQ) is the drug of choice for treating infection with worms from the\ngenus Schistosoma. The drug is effective, cheap and has few side effects. However, despite its\nuse in millions of patients for over 40 years its molecular mechanism of action remains elusive.\nEarly studies demonstrated that PZQ disrupts calcium ion homeostasis in the worm and\nthe current consensus is that it antagonises voltage-gated calcium channels. It is hypothesised\nthat disruption of these channels results in uncontrolled calcium ion influx leading to uncontrolled\nmuscle contraction and paralysis. However, other experimental studies have suggested\na role for myosin regulatory light chains and adenosine uptake in the drug\u2019s mechanism of\naction. Assuming voltage-gated calcium channels do represent the main molecular target of\nPZQ, the precise binding site for the drug remains to be identified. Unlike other commonly\nused anti-parasitic drugs, there are few definitive reports of resistance to PZQ in the literature.\nThe lack of knowledge about PZQ\u2019s molecular mechanism(s) undermines our ability to predict\nhow resistance might arise and also hinder our attempts to develop alternative antischistosomal\ndrugs which exploit the same target(s). Some PZQ derivatives have been identified\nwhich also kill or paralyse schistosomes in culture. However, none of these are in widespread\nclinical use. There is a pressing need for fundamental research into the molecular mechanism(\ns) of action of PZQ. Such research would enable new avenues for antischsistosomal\ndrug discovery.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867325666180926145537","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T11:44:50Z","timestamp":1538048690000},"page":"676-696","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["The Mechanism of Action of Praziquantel: Can New Drugs Exploit Similar Mechanisms?"],"prefix":"10.2174","volume":"27","author":[{"given":"Charlotte M.","family":"Thomas","sequence":"first","affiliation":[{"name":"School of Biological Sciences, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Timson","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2012.13727","volume":"142","author":"Utzinger J.","year":"2012","unstructured":"Utzinger J.; Becker S.L.; Knopp S.; Blum J.; Neumayr A.L.; Keiser J.; Hatz C.F.; Neglected tropical diseases: diagnosis, clinical management, treatment and control. Swiss Med Wkly 2012,142","journal-title":"Swiss Med Wkly"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1017\/S0031182009991600","volume":"136","author":"Utzinger J.","year":"2009","unstructured":"Utzinger J.; Raso G.; Brooker S.; De Savigny D.; Tanner M.; Ornbjerg N.; Singer B.H.; N\u2019goran E.K.; Schistosomiasis and neglected tropical diseases: towards integrated and sustainable control and a word of caution. Parasitology 2009,136(13),1859-1874","journal-title":"Parasitology"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S0140-6736(06)69440-3","volume":"368","author":"Gryseels B.","year":"2006","unstructured":"Gryseels B.; Polman K.; Clerinx J.; Kestens L.; Human schistosomiasis. Lancet 2006,368(9541),1106-1118","journal-title":"Lancet"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S1473-3099(06)70521-7","volume":"6","author":"Steinmann P.","year":"2006","unstructured":"Steinmann P.; Keiser J.; Bos R.; Tanner M.; Utzinger J.; Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 2006,6(7),411-425","journal-title":"Lancet Infect Dis"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0001-706X(03)00029-9","volume":"86","author":"van der Werf M.J.","year":"2003","unstructured":"van der Werf M.J.; de Vlas S.J.; Brooker S.; Looman C.W.; Nagelkerke N.J.; Habbema J.D.; Engels D.; Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 2003,86(2-3),125-139","journal-title":"Acta Trop"},{"key":"ref=6","first-page":"235","volume":"80","author":"Lengeler C.","year":"2002","unstructured":"Lengeler C.; Utzinger J.; Tanner M.; Questionnaires for rapid screening of schistosomiasis in sub-Saharan Africa. Bull World Health Organ 2002,80(3),235-242","journal-title":"Bull World Health Organ"},{"key":"ref=7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000539","volume":"3","author":"Hotez P.J.","year":"2009","unstructured":"Hotez P.J.; The neglected tropical diseases and their devastating health and economic impact on the member nations of the organisation of the Islamic Conference. PLoS Negl Trop Dis 2009,3(10)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000412","volume":"3","author":"Hotez P.J.","year":"2009","unstructured":"Hotez P.J.; Kamath A.; Neglected tropical diseases in sub-saharan Africa: review of their prevalence, distribution, and disease burden. PLoS Negl Trop Dis 2009,3(8)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ijpara.2014.04.001","volume":"44","author":"Hotez P.J.","year":"2014","unstructured":"Hotez P.J.; Woc-Colburn L.; Bottazzi M.E.; Neglected tropical diseases in Central America and Panama: review of their prevalence, populations at risk and impact on regional development. Int J Parasitol 2014,44(9),597-603","journal-title":"Int J Parasitol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/0169-4758(96)80657-0","volume":"12","author":"Blair D.","year":"1996","unstructured":"Blair D.; Campos A.; Cummings M.P.; Laclette J.P.; Evolutionary biology of parasitic platyhelminths: The role of molecular phylogenetics. Parasitol Today (Regul Ed) 1996,12(2),66-71","journal-title":"Parasitol Today (Regul Ed)"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S0020-7519(03)00049-3","volume":"33","author":"Olson P.D.","year":"2003","unstructured":"Olson P.D.; Cribb T.H.; Tkach V.V.; Bray R.A.; Littlewood D.T.; Phylogeny and classification of the Digenea (Platyhelminthes: Trematoda). Int J Parasitol 2003,33(7),733-755","journal-title":"Int J Parasitol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/1756-3305-4-203","volume":"4","author":"Walker A.J.","year":"2011","unstructured":"Walker A.J.; Insights into the functional biology of schistosomes. Parasit Vectors 2011,4,203","journal-title":"Parasit Vectors"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","volume":"383","author":"Colley D.G.","year":"2014","unstructured":"Colley D.G.; Bustinduy A.L.; Secor W.E.; King C.H.; Human schistosomiasis. Lancet 2014,383(9936),2253-2264","journal-title":"Lancet"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0014-4894(03)00024-9","volume":"102","author":"He Y.X.","year":"2002","unstructured":"He Y.X.; Chen L.; Ramaswamy K.; \n                        Schistosoma mansoni, S. haematobium, and S. japonicum: early events associated with penetration and migration of schistosomula through human skin. Exp Parasitol 2002,102(2),99-108","journal-title":"Exp Parasitol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"238","DOI":"10.4269\/ajtmh.1992.47.238","volume":"47","author":"Dean D.A.","year":"1992","unstructured":"Dean D.A.; Mangold B.L.; Evidence that both normal and immune elimination of Schistosoma mansoni take place at the lung stage of migration prior to parasite death. Am J Trop Med Hyg 1992,47(2),238-248","journal-title":"Am J Trop Med Hyg"},{"key":"ref=16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001009","volume":"5","author":"Collins J.J.","year":"2011","unstructured":"Collins J.J.; King R.S.; Cogswell A.; Williams D.L.; Newmark P.A.; An atlas for Schistosoma mansoni organs and life-cycle stages using cell type-specific markers and confocal microscopy. PLoS Negl Trop Dis 2011,5(3)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1365-3024.2009.01098.x","volume":"31","author":"Burke M.L.","year":"2009","unstructured":"Burke M.L.; Jones M.K.; Gobert G.N.; Li Y.S.; Ellis M.K.; McManus D.P.; Immunopathogenesis of human schistosomiasis. Parasite Immunol 2009,31(4),163-176","journal-title":"Parasite Immunol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S1473-3099(07)70053-1","volume":"7","author":"Ross A.G.","year":"2007","unstructured":"Ross A.G.; Vickers D.; Olds G.R.; Shah S.M.; McManus D.P.; Katayama syndrome. Lancet Infect Dis 2007,7(3),218-224","journal-title":"Lancet Infect Dis"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00415-011-6133-7","volume":"259","author":"Ross A.G.","year":"2012","unstructured":"Ross A.G.; McManus D.P.; Farrar J.; Hunstman R.J.; Gray D.J.; Li Y.S.; Neuroschistosomiasis. J Neurol 2012,259(1),22-32","journal-title":"J Neurol"},{"key":"ref=20","first-page":"1","volume":"33","author":"Schwartz D.A.","year":"1981","unstructured":"Schwartz D.A.; Helminths in the induction of cancer II. Schistosoma haematobium and bladder cancer. Trop Geogr Med 1981,33(1),1-7","journal-title":"Trop Geogr Med"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/BF00507974","volume":"304","author":"Pax R.","year":"1978","unstructured":"Pax R.; Bennett J.L.; Fetterer R.; A benzodiazepine derivative and praziquantel: effects on musculature of Schistosoma mansoni and Schistosoma japonicum. Naunyn Schmiedebergs Arch Pharmacol 1978,304(3),309-315","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1017\/S0022149X00005691","volume":"53","author":"Coles G.C.","year":"1979","unstructured":"Coles G.C.; The effect of praziquantel on Schistosoma mansoni. J Helminthol 1979,53(1),31-33","journal-title":"J Helminthol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.molbiopara.2014.06.002","volume":"195","author":"Cioli D.","year":"2014","unstructured":"Cioli D.; Pica-Mattoccia L.; Basso A.; Guidi A.; Schistosomiasis control: praziquantel forever? Mol Biochem Parasitol 2014,195(1),23-29","journal-title":"Mol Biochem Parasitol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1007\/s00436-002-0751-z","volume":"90","author":"Cioli D.","year":"2003","unstructured":"Cioli D.; Pica-Mattoccia L.; Praziquantel. Parasitol Res 2003,90(Suppl. 1),S3-S9","journal-title":"Parasitol Res"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1097\/QCO.0b013e328318978f","volume":"21","author":"Doenhoff M.J.","year":"2008","unstructured":"Doenhoff M.J.; Cioli D.; Utzinger J.; Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis 2008,21(6),659-667","journal-title":"Curr Opin Infect Dis"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1016\/j.bmc.2017.04.031","volume":"25","author":"da Silva V.B.R.","year":"2017","unstructured":"da Silva V.B.R.; Campos B.R.K.L.; de Oliveira J.F.; Decout J.L.; do Carmo Alves de Lima M.; Medicinal chemistry of antischistosomal drugs: Praziquantel and oxamniquine. Bioorg Med Chem 2017,25(13),3259-3277","journal-title":"Bioorg Med Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0163-7258(95)00026-7","volume":"68","author":"Cioli D.","year":"1995","unstructured":"Cioli D.; Pica-Mattoccia L.; Archer S.; Antischistosomal drugs: past, present and future? Pharmacol Ther 1995,68(1),35-85","journal-title":"Pharmacol Ther"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0035-9203(87)90282-3","volume":"81","author":"Foster R.","year":"1987","unstructured":"Foster R.; A review of clinical experience with oxamniquine. Trans R Soc Trop Med Hyg 1987,81(1),55-59","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4269\/ajtmh.1985.34.112","volume":"34","author":"Pica-Mattoccia L.","year":"1985","unstructured":"Pica-Mattoccia L.; Cioli D.; Studies on the mode of action of oxamniquine and related schistosomicidal drugs. Am J Trop Med Hyg 1985,34(1),112-118","journal-title":"Am J Trop Med Hyg"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0035-9203(89)90508-7","volume":"83","author":"Pica-Mattoccia L.","year":"1989","unstructured":"Pica-Mattoccia L.; Cioli D.; Archer S.; Binding of oxamniquine to the DNA of schistosomes. Trans R Soc Trop Med Hyg 1989,83(3),373-376","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1590\/S0074-02762006000900048","volume":"101","author":"Pica-Mattoccia L.","year":"2006","unstructured":"Pica-Mattoccia L.; Carlini D.; Guidi A.; Cimica V.; Vigorosi F.; Cioli D.; The schistosome enzyme that activates oxamniquine has the characteristics of a sulfotransferase. Mem Inst Oswaldo Cruz 2006,101(Suppl. 1),307-312","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"11154","DOI":"10.1074\/jbc.M116.766527","volume":"292","author":"Taylor A.B.","year":"2017","unstructured":"Taylor A.B.; Roberts K.M.; Cao X.; Clark N.E.; Holloway S.P.; Donati E.; Polcaro C.M.; Pica-Mattoccia L.; Tarpley R.S.; McHardy S.F.; Cioli D.; LoVerde P.T.; Fitzpatrick P.F.; Hart P.J.; Structural and enzymatic insights into species-specific resistance to schistosome parasite drug therapy. J Biol Chem 2017,292(27),11154-11164","journal-title":"J Biol Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ijpara.2016.03.006","volume":"46","author":"Chevalier F.D.","year":"2016","unstructured":"Chevalier F.D.; Le Clec\u2019h W.; Eng N.; Rugel A.R.; Assis R.R.; Oliveira G.; Holloway S.P.; Cao X.; Hart P.J.; LoVerde P.T.; Anderson T.J.; Independent origins of loss-of-function mutations conferring oxamniquine resistance in a Brazilian schistosome population. Int J Parasitol 2016,46(7),417-424","journal-title":"Int J Parasitol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3947\/ic.2013.45.1.32","volume":"45","author":"Chai J.Y.","year":"2013","unstructured":"Chai J.Y.; Praziquantel treatment in trematode and cestode infections: an update. Infect Chemother 2013,45(1),32-43","journal-title":"Infect Chemother"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3354\/dao03054","volume":"121","author":"Forwood J.M.","year":"2016","unstructured":"Forwood J.M.; Bubner E.J.; Landos M.; Deveney M.R.; D\u2019Antignana T.; Praziquantel delivery via moist pellets to treat monogenean parasites of yellowtail kingfish Seriola lalandi: efficacy and feed acceptance. Dis Aquat Organ 2016,121(3),201-209","journal-title":"Dis Aquat Organ"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1017\/S0022149X14000601","volume":"90","author":"Scala A.","year":"2016","unstructured":"Scala A.; Urrai G.; Varcasia A.; Nicolussi P.; Mulas M.; Goddi L.; Pipia A.P.; Sanna G.; Genchi M.; Bandino E.; Acute visceral cysticercosis by Taenia hydatigena in lambs and treatment with praziquantel. J Helminthol 2016,90(1),113-116","journal-title":"J Helminthol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s40249-017-0357-4","volume":"6","author":"Jiang B.","year":"2017","unstructured":"Jiang B.; Zhou X.N.; Zhang H.B.; Tao Y.; Huo L.L.; Liu N.; Slow-release praziquantel for dogs: presentation of a new formulation for echinococcosis control. Infect Dis Poverty 2017,6(1),140","journal-title":"Infect Dis Poverty"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/jvp.12378","volume":"40","author":"Qian M.","year":"2017","unstructured":"Qian M.; Wei L.; Hao L.; Tang S.; Pharmacokinetics of new high-concentration and long-acting praziquantel oily suspensions after intramuscular administration in cattle. J Vet Pharmacol Ther 2017,40(5),454-458","journal-title":"J Vet Pharmacol Ther"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.7717\/peerj.1857","volume":"4e","author":"Thomas A.","year":"2016","unstructured":"Thomas A.; Dawson M.R.; Ellis H.; Stamper M.A.; Praziquantel degradation in marine aquarium water. PeerJ 2016,4e,1857","journal-title":"PeerJ"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ijid.2004.08.001","volume":"9","author":"Smego R.A.","year":"2005","unstructured":"Smego R.A.; Sebanego P.; Treatment options for hepatic cystic echinococcosis. International journal of infectious diseases: IJID : official publication of the International Society for Infectious Diseases 2005,9(2),69-76","journal-title":"International journal of infectious diseases: IJID : official publication of the International Society for Infectious Diseases"},{"key":"ref=41","first-page":"79","volume":"89","author":"Farag H.F.","year":"1986","unstructured":"Farag H.F.; Ragab M.; Salem A.; Sadek N.; A short note on praziquantel in human fascioliasis. J Trop Med Hyg 1986,89(2),79-80","journal-title":"J Trop Med Hyg"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/0035-9203(89)90339-8","volume":"83","author":"Farid Z.","year":"1989","unstructured":"Farid Z.; Kamal M.; Mansour N.; Praziquantel and Fasciola hepatica infection. Trans R Soc Trop Med Hyg 1989,83(6),813","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1155\/1992\/864093","volume":"3","author":"Patrick D.M.","year":"1992","unstructured":"Patrick D.M.; Isaac-Renton J.; Praziquantel failure in the treatment of Fasciola hepatica. Can J Infect Dis 1992,3(1),33-36","journal-title":"Can J Infect Dis"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/0014-4894(85)90041-4","volume":"60","author":"Sabah A.A.","year":"1985","unstructured":"Sabah A.A.; Fletcher C.; Webbe G.; Doenhoff M.J.; \n                        Schistosoma mansoni: reduced efficacy of chemotherapy in infected T-cell-deprived mice. Exp Parasitol 1985,60(3),348-354","journal-title":"Exp Parasitol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ijpara.2003.12.003","volume":"34","author":"Pica-Mattoccia L.","year":"2004","unstructured":"Pica-Mattoccia L.; Cioli D.; \n                        Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment. Int J Parasitol 2004,34(4),527-533","journal-title":"Int J Parasitol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.ijpara.2005.05.002","volume":"35","author":"Botros S.","year":"2005","unstructured":"Botros S.; Pica-Mattoccia L.; William S.; El-Lakkani N.; Cioli D.; Effect of praziquantel on the immature stages of Schistosoma haematobium. Int J Parasitol 2005,35(13),1453-1457","journal-title":"Int J Parasitol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/QCO.0000000000000312","volume":"29","author":"Olveda D.U.","year":"2016","unstructured":"Olveda D.U.; McManus D.P.; Ross A.G.; Mass drug administration and the global control of schistosomiasis: successes, limitations and clinical outcomes. Curr Opin Infect Dis 2016,29(6),595-608","journal-title":"Curr Opin Infect Dis"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1016\/S1473-3099(16)30475-3","volume":"17","author":"Mutapi F.","year":"2017","unstructured":"Mutapi F.; Maizels R.; Fenwick A.; Woolhouse M.; Human schistosomiasis in the post mass drug administration era. Lancet Infect Dis 2017,17(2),e42-e48","journal-title":"Lancet Infect Dis"},{"key":"ref=49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003059","volume":"8","author":"Mitchell K.M.","year":"2014","unstructured":"Mitchell K.M.; Mutapi F.; Mduluza T.; Midzi N.; Savill N.J.; Woolhouse M.E.; Predicted impact of mass drug administration on the development of protective immunity against Schistosoma haematobium. PLoS Negl Trop Dis 2014,8(7)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000897","volume":"4","author":"French M.D.","year":"2010","unstructured":"French M.D.; Churcher T.S.; Gambhir M.; Fenwick A.; Webster J.P.; Kabatereine N.B.; Bas\u00e1\u00f1ez M.G.; Observed reductions in Schistosoma mansoni transmission from large-scale administration of praziquantel in Uganda: a mathematical modelling study. PLoS Negl Trop Dis 2010,4(11)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/QCO.0b013e328357e4cf","volume":"25","author":"Humphries D.","year":"2012","unstructured":"Humphries D.; Nguyen S.; Boakye D.; Wilson M.; Cappello M.; The promise and pitfalls of mass drug administration to control intestinal helminth infections. Curr Opin Infect Dis 2012,25(5),584-589","journal-title":"Curr Opin Infect Dis"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S1054-3589(08)60268-9","volume":"20","author":"Groll E.","year":"1984","unstructured":"Groll E.; Praziquantel. Adv Pharmacol Chemother 1984,20,219-238","journal-title":"Adv Pharmacol Chemother"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/med.2610030204","volume":"3","author":"Andrews P.","year":"1983","unstructured":"Andrews P.; Thomas H.; Pohlke R.; Seubert J.; Praziquantel. Med Res Rev 1983,3(2),147-200","journal-title":"Med Res Rev"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/BF00560463","volume":"14","author":"Leopold G.","year":"1978","unstructured":"Leopold G.; Ungeth\u00fcm W.; Groll E.; Diekmann H.W.; Nowak H.; Wegner D.H.; Clinical pharmacology in normal volunteers of praziquantel, a new drug against schistosomes and cestodes. An example of a complex study covering both tolerance and pharmacokinetics. Eur J Clin Pharmacol 1978,14(4),281-291","journal-title":"Eur J Clin Pharmacol"},{"key":"ref=55","first-page":"767","volume":"57","author":"Davis A.","year":"1979","unstructured":"Davis A.; Wegner D.H.; Multicentre trials of praziquantel in human schistosomiasis: design and techniques. Bull World Health Organ 1979,57(5),767-771","journal-title":"Bull World Health Organ"},{"key":"ref=56","first-page":"544","volume":"31","author":"Mehlhorn H.","year":"1981","unstructured":"Mehlhorn H.; Becker B.; Andrews P.; Thomas H.; Frenkel J.K.; \n                        In vivo and in vitro experiments on the effects of praziquantel on Schistosoma mansoni. A light and electron microscopic study. Arzneimittelforschung 1981,31(3a),544-554","journal-title":"Arzneimittelforschung"},{"key":"ref=57","first-page":"935","volume":"99","author":"Liu Y.H.","year":"1986","unstructured":"Liu Y.H.; Qian M.X.; Wang X.G.; Jia J.; Wang Q.N.; Jiang Y.F.; Wang R.Q.; Yan S.H.; Chen B.Y.; Li J.S.; Comparative efficacy of praziquantel and its optic isomers in experimental therapy of Schistosomiasis japonica in rabbits. Chin Med J (Engl) 1986,99(12),935-940","journal-title":"Chin Med J (Engl)"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/infdis\/159.3.589","volume":"159","author":"Xiao S.H.","year":"1989","unstructured":"Xiao S.H.; Catto B.A.; Comparative in vitro and in vivo activity of racemic praziquantel and its levorotated isomer on Schistosoma mansoni. J Infect Dis 1989,159(3),589-592","journal-title":"J Infect Dis"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"198","DOI":"10.4269\/ajtmh.1989.41.198","volume":"41","author":"Tanaka M.","year":"1989","unstructured":"Tanaka M.; Ohmae H.; Utsunomiya H.; Nara T.; Irie Y.; Yasuraoka K.; A comparison of the antischistosomal effect of levo- and dextro-praziquantel on Schistosoma japonicum and S. mansoni in mice. Am J Trop Med Hyg 1989,41(2),198-203","journal-title":"Am J Trop Med Hyg"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00436-009-1371-7","volume":"104","author":"Abdul-Ghani R.","year":"2009","unstructured":"Abdul-Ghani R.; Loutfy N.; el-Sahn A.; Hassan A.; Current chemotherapy arsenal for Schistosomiasis mansoni: alternatives and challenges. Parasitol Res 2009,104(5),955-965","journal-title":"Parasitol Res"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"345","DOI":"10.4269\/ajtmh.1991.45.345","volume":"45","author":"Wu M.H.","year":"1991","unstructured":"Wu M.H.; Wei C.C.; Xu Z.Y.; Yuan H.C.; Lian W.N.; Yang Q.J.; Chen M.; Jiang Q.W.; Wang C.Z.; Zhang S.J.; Comparison of the therapeutic efficacy and side effects of a single dose of levo-praziquantel with mixed isomer praziquantel in 278 cases of Schistosomiasis japonica. Am J Trop Med Hyg 1991,45(3),345-349","journal-title":"Am J Trop Med Hyg"},{"key":"ref=62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000357","volume":"3","author":"Meyer T.","year":"2009","unstructured":"Meyer T.; Sekljic H.; Fuchs S.; Bothe H.; Schollmeyer D.; Miculka C.; Taste, a new incentive to switch to (R)-praziquantel in schistosomiasis treatment. PLoS Negl Trop Dis 2009,3(1)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.tetasy.2006.04.023","volume":"17","author":"Roszkowski P.","year":"2006","unstructured":"Roszkowski P.; Maurin J.K.; Czarnocki Z.; Enantioselective synthesis of (R)-(\u2212)-praziquantel (PZQ). Tetrahedron Asymmetry 2006,17(9),1415-1419","journal-title":"Tetrahedron Asymmetry"},{"key":"ref=64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001260","volume":"5","author":"Woelfle M.","year":"2011","unstructured":"Woelfle M.; Seerden J.P.; de Gooijer J.; Pouwer K.; Olliaro P.; Todd M.H.; Resolution of praziquantel. PLoS Negl Trop Dis 2011,5(9)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1002\/jps.20211","volume":"93","author":"Liu Y.","year":"2004","unstructured":"Liu Y.; Wang X.; Wang J.K.; Ching C.B.; Structural characterization and enantioseparation of the chiral compound praziquantel. J Pharm Sci 2004,93(12),3039-3046","journal-title":"J Pharm Sci"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0021-9673(93)83007-F","volume":"634","author":"Ching C.B.","year":"1993","unstructured":"Ching C.B.; Lim B.G.; Lee E.J.D.; Ng S.C.; Preparative resolution of praziquantel enantiomers by simulated counter-current chromatography. J Chromatogr A 1993,634(2),215-219","journal-title":"J Chromatogr A"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1016\/0009-2509(95)00082-G","volume":"50","author":"Lim B.G.","year":"1995","unstructured":"Lim B.G.; Ching C.B.; Tan R.B.H.; Ng S.C.; Recovery of (\u2212)-praziquantel from racemic mixtures by continuous chromatography and crystallisation. Chem Eng Sci 1995,50(14),2289-2298","journal-title":"Chem Eng Sci"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ejpb.2004.03.001","volume":"58","author":"Lindenberg M.","year":"2004","unstructured":"Lindenberg M.; Kopp S.; Dressman J.B.; Classification of orally administered drugs on the World Health Organization Model list of essential medicines according to the biopharmaceutics classification system. Eur J Pharm Biopharm 2004,58(2),265-278","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ijpharm.2006.03.028","volume":"318","author":"Passerini N.","year":"2006","unstructured":"Passerini N.; Albertini B.; Perissutti B.; Rodriguez L.; Evaluation of melt granulation and ultrasonic spray congealing as techniques to enhance the dissolution of praziquantel. Int J Pharm 2006,318(1-2),92-102","journal-title":"Int J Pharm"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/0006-2952(94)90464-2","volume":"48","author":"Masimirembwa C.M.","year":"1994","unstructured":"Masimirembwa C.M.; Hasler J.A.; Characterisation of praziquantel metabolism by rat liver microsomes using cytochrome P450 inhibitors. Biochem Pharmacol 1994,48(9),1779-1783","journal-title":"Biochem Pharmacol"},{"key":"ref=71","first-page":"381","volume":"63","author":"Godawska-Matysik A.","year":"2006","unstructured":"Godawska-Matysik A.; Kie\u0107-Kononowicz K.; Biotransformation of praziquantel by human cytochrome p450 3A4 (CYP 3A4). Acta Pol Pharm 2006,63(5),381-385","journal-title":"Acta Pol Pharm"},{"key":"ref=72","first-page":"75","volume":"61","author":"Godawska-Matysik A.","year":"2004","unstructured":"Godawska-Matysik A.; Pekala E.; Kiec-Kononowicz K.; The research on biotransformation of praziquantel. Acta\npoloniae pharmaceutica 2004,61(Suppl.),75-78","journal-title":"Acta\npoloniae pharmaceutica"},{"key":"ref=73","first-page":"33","volume":"40","author":"Castro N.","year":"1997","unstructured":"Castro N.; Gonz\u00e0lez-Esquivel D.; Medina R.; Sotelo J.; Jung H.; The influence of cimetidine on plasma levels of praziquantel after a single day therapeutic regimen. Proc West Pharmacol Soc 1997,40,33-34","journal-title":"Proc West Pharmacol Soc"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1128\/AAC.41.6.1256","volume":"41","author":"Jung H.","year":"1997","unstructured":"Jung H.; Medina R.; Castro N.; Corona T.; Sotelo J.; Pharmacokinetic study of praziquantel administered alone and in combination with cimetidine in a single-day therapeutic regimen. Antimicrob Agents Chemother 1997,41(6),1256-1259","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1128\/AAC.44.10.2903-2904.2000","volume":"44","author":"Castro N.","year":"2000","unstructured":"Castro N.; Medina R.; Sotelo J.; Jung H.; Bioavailability of praziquantel increases with concomitant administration of food. Antimicrob Agents Chemother 2000,44(10),2903-2904","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.01.033","volume":"295","author":"Gonz\u00e1lez-Esquivel D.","year":"2005","unstructured":"Gonz\u00e1lez-Esquivel D.; Rivera J.; Castro N.; Yepez-Mulia L.; Jung Cook H.; \n                        In vitro characterization of some biopharmaceutical properties of praziquantel. Int J Pharm 2005,295(1-2),93-99","journal-title":"Int J Pharm"},{"key":"ref=77","first-page":"120","volume":"26","author":"Na-Bangchang K.","year":"1995","unstructured":"Na-Bangchang K.; Vanijanonta S.; Karbwang J.; Plasma concentrations of praziquantel during the therapy of neurocysticerosis with praziquantel, in the presence of antiepileptics and dexamethasone. Southeast Asian J Trop Med Public Health 1995,26(1),120-123","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2165\/00003088-199834060-00006","volume":"34","author":"Sotelo J.","year":"1998","unstructured":"Sotelo J.; Jung H.; Pharmacokinetic optimisation of the treatment of neurocysticercosis. Clin Pharmacokinet 1998,34(6),503-515","journal-title":"Clin Pharmacokinet"},{"key":"ref=79","first-page":"495","volume":"14","author":"Chen M.G.","year":"1983","unstructured":"Chen M.G.; Fu S.; Hua X.J.; Wu H.M.; A retrospective survey on side effects of praziquantel among 25,693 cases of Schistosomiasis japonica. Southeast Asian J Trop Med Public Health 1983,14(4),495-500","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpara.2004.09.004","volume":"35","author":"Greenberg R.M.","year":"2005","unstructured":"Greenberg R.M.; Are Ca channels targets of praziquantel action? Int J Parasitol 2005,35(1),1-9","journal-title":"Int J Parasitol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/wmts.19","volume":"1","author":"Salvador-Recatal\u00e0 V.","year":"2012","unstructured":"Salvador-Recatal\u00e0 V.; Greenberg R.M.; Calcium channels of schistosomes: unresolved questions and unexpected answers. Wiley Interdiscip Rev Membr Transp Signal 2012,1(1),85-93","journal-title":"Wiley Interdiscip Rev Membr Transp Signal"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0014-2999(80)90366-0","volume":"64","author":"Fetterer R.H.","year":"1980","unstructured":"Fetterer R.H.; Pax R.A.; Bennett J.L.; Praziquantel, potassium and 2,4-dinitrophenol: analysis of their action on the musculature of Schistosoma mansoni. Eur J Pharmacol 1980,64(1),31-38","journal-title":"Eur J Pharmacol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/BF00927527","volume":"63","author":"Becker B.","year":"1980","unstructured":"Becker B.; Mehlhorn H.; Andrews P.; Thomas H.; Eckert J.; Light and electron microscopic studies on the effect of praziquantel on Schistosoma mansoni, Dicrocoelium dendriticum, and Fasciola hepatica (Trematoda) in vitro. Z Parasitenkd 1980,63(2),113-128","journal-title":"Z Parasitenkd"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1139\/z03-213","volume":"82","author":"Dalton J.P.","year":"2004","unstructured":"Dalton J.P.; Skelly P.; Halton D.W.; Role of the tegument and gut in nutrient uptake by parasitic platyhelminths. Can J Zool 2004,82(2),211-232","journal-title":"Can J Zool"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/0014-4894(82)90069-8","volume":"53","author":"Wolde Mussie E.","year":"1982","unstructured":"Wolde Mussie E.; Vande Waa J.; Pax R.A.; Fetterer R.; Bennett J.L.; \n                        Schistosoma mansoni: calcium efflux and effects of calcium-free media on responses of the adult male musculature to praziquantel and other agents inducing contraction. Exp Parasitol 1982,53(2),270-278","journal-title":"Exp Parasitol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1017\/S0031182000051568","volume":"93","author":"Harnett W.","year":"1986","unstructured":"Harnett W.; Kusel J.R.; Increased exposure of parasite antigens at the surface of adult male Schistosoma mansoni exposed to praziquantel in vitro. Parasitology 1986,93(Pt 2),401-405","journal-title":"Parasitology"},{"key":"ref=87","first-page":"91","volume":"33","author":"Mehlhorn H.","year":"1983","unstructured":"Mehlhorn H.; Kojima S.; Rim H.J.; Ruenwongsa P.; Andrews P.; Thomas H.; Bunnag B.; Ultrastructural investigations on the effects of praziquantel on human trematodes from Asia: Clonorchis sinensis, Metagonimus yokogawai, Opisthorchis viverrini, Paragonimus westermani and Schistosoma japonicum. Arzneimittelforschung 1983,33(1),91-98","journal-title":"Arzneimittelforschung"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/BF00927373","volume":"64","author":"Becker B.","year":"1981","unstructured":"Becker B.; Mehlhorn H.; Andrews P.; Thomas H.; Ultrastructural investigations on the effect of praziquantel on the tegument of five species of cestodes. Z Parasitenkd 1981,64(3),257-269","journal-title":"Z Parasitenkd"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1017\/S0031182000060807","volume":"104","author":"Blair K.L.","year":"1992","unstructured":"Blair K.L.; Bennett J.L.; Pax R.A.; Praziquantel: physiological evidence for its site(s) of action in magnesium-paralysed Schistosoma mansoni. Parasitology 1992,104(Pt 1),59-66","journal-title":"Parasitology"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1023\/B:JOBB.0000008026.37790.5a","volume":"35","author":"Dolphin A.C.","year":"2003","unstructured":"Dolphin A.C.; Beta subunits of voltage-gated calcium channels. J Bioenerg Biomembr 2003,35(6),599-620","journal-title":"J Bioenerg Biomembr"},{"key":"ref=91","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a003947","volume":"3","author":"Catterall W.A.","year":"2011","unstructured":"Catterall W.A.; Voltage-gated calcium channels. Cold Spring Harb Perspect Biol 2011,3(8)","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"459","DOI":"10.4161\/chan.4.6.12867","volume":"4","author":"Minor D.L.","year":"2010","unstructured":"Minor D.L.; Findeisen F.; Progress in the structural understanding of voltage-gated calcium channel (CaV) function and modulation. Channels (Austin) 2010,4(6),459-474","journal-title":"Channels (Austin)"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1038\/emboj.2010.260","volume":"29","author":"Kim E.Y.","year":"2010","unstructured":"Kim E.Y.; Rumpf C.H.; Van Petegem F.; Arant R.J.; Findeisen F.; Cooley E.S.; Isacoff E.Y.; Minor D.L.; Multiple C-terminal tail Ca()\/CaMs regulate Ca(V)1.2 function but do not mediate channel dimerization. EMBO J 2010,29(23),3924-3938","journal-title":"EMBO J"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1023\/A:1021981420839","volume":"30","author":"Perez-Reyes E.","year":"1998","unstructured":"Perez-Reyes E.; Molecular characterization of a novel family of low voltage-activated, T-type, calcium channels. J Bioenerg Biomembr 1998,30(4),313-318","journal-title":"J Bioenerg Biomembr"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0896-6273(00)80709-6","volume":"22","author":"Peterson B.Z.","year":"1999","unstructured":"Peterson B.Z.; DeMaria C.D.; Adelman J.P.; Yue D.T.; Calmodulin is the Ca sensor for Ca -dependent inactivation of L-type calcium channels. Neuron 1999,22(3),549-558","journal-title":"Neuron"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S0896-6273(01)00438-X","volume":"31","author":"Erickson M.G.","year":"2001","unstructured":"Erickson M.G.; Alseikhan B.A.; Peterson B.Z.; Yue D.T.; Preassociation of calmodulin with voltage-gated Ca() channels revealed by FRET in single living cells. Neuron 2001,31(6),973-985","journal-title":"Neuron"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"30794","DOI":"10.1074\/jbc.M104959200","volume":"276","author":"Pitt G.S.","year":"2001","unstructured":"Pitt G.S.; Z\u00fchlke R.D.; Hudmon A.; Schulman H.; Reuter H.; Tsien R.W.; Molecular basis of calmodulin tethering and Ca-dependent inactivation of L-type Ca channels. J Biol Chem 2001,276(33),30794-30802","journal-title":"J Biol Chem"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/20200","volume":"399","author":"Z\u00fchlke R.D.","year":"1999","unstructured":"Z\u00fchlke R.D.; Pitt G.S.; Deisseroth K.; Tsien R.W.; Reuter H.; Calmodulin supports both inactivation and facilitation of L-type calcium channels. Nature 1999,399(6732),159-162","journal-title":"Nature"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"36873","DOI":"10.1074\/jbc.C100273200","volume":"276","author":"Kohn A.B.","year":"2001","unstructured":"Kohn A.B.; Anderson P.A.; Roberts-Misterly J.M.; Greenberg R.M.; Schistosome calcium channel beta subunits. Unusual modulatory effects and potential role in the action of the antischistosomal drug praziquantel. J Biol Chem 2001,276(40),36873-36876","journal-title":"J Biol Chem"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S0020-7519(03)00209-1","volume":"33","author":"Kohn A.B.","year":"2003","unstructured":"Kohn A.B.; Roberts-Misterly J.M.; Anderson P.A.; Greenberg R.M.; Creation by mutagenesis of a mammalian Ca() channel beta subunit that confers praziquantel sensitivity to a mammalian Ca() channel. Int J Parasitol 2003,33(12),1303-1308","journal-title":"Int J Parasitol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1017\/S003118200300386X","volume":"127","author":"Kohn A.B.","year":"2003","unstructured":"Kohn A.B.; Roberts-Misterly J.M.; Anderson P.A.; Khan N.; Greenberg R.M.; Specific sites in the beta interaction domain of a schistosome Ca channel beta subunit are key to its role in sensitivity to the anti-schistosomal drug praziquantel. Parasitology 2003,127(Pt 4),349-356","journal-title":"Parasitology"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"701","DOI":"10.4155\/fmc.15.11","volume":"7","author":"Cupit P.M.","year":"2015","unstructured":"Cupit P.M.; Cunningham C.; What is the mechanism of action of praziquantel and how might resistance strike? Future Med Chem 2015,7(6),701-705","journal-title":"Future Med Chem"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/nature02641","volume":"429","author":"Chen Y.H.","year":"2004","unstructured":"Chen Y.H.; Li M.H.; Zhang Y.; He L.L.; Yamada Y.; Fitzmaurice A.; Shen Y.; Zhang H.; Tong L.; Yang J.; Structural basis of the alpha1-beta subunit interaction of voltage-gated Ca channels. Nature 2004,429(6992),675-680","journal-title":"Nature"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0166-6851(03)00171-3","volume":"130","author":"Valle C.","year":"2003","unstructured":"Valle C.; Troiani A.R.; Festucci A.; Pica-Mattoccia L.; Liberti P.; Wolstenholme A.; Francklow K.; Doenhoff M.J.; Cioli D.; Sequence and level of endogenous expression of calcium channel beta subunits in Schistosoma mansoni displaying different susceptibilities to praziquantel. Mol Biochem Parasitol 2003,130(2),111-115","journal-title":"Mol Biochem Parasitol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.molbiopara.2008.11.007","volume":"164","author":"Aragon A.D.","year":"2009","unstructured":"Aragon A.D.; Imani R.A.; Blackburn V.R.; Cupit P.M.; Melman S.D.; Goronga T.; Webb T.; Loker E.S.; Cunningham C.; Towards an understanding of the mechanism of action of praziquantel. Mol Biochem Parasitol 2009,164(1),57-65","journal-title":"Mol Biochem Parasitol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.exppara.2008.03.012","volume":"119","author":"Pica-Mattoccia L.","year":"2008","unstructured":"Pica-Mattoccia L.; Orsini T.; Basso A.; Festucci A.; Liberti P.; Guidi A.; Marcatto-Maggi A.L.; Nobre-Santana S.; Troiani A.R.; Cioli D.; Valle C.; \n                        Schistosoma mansoni: lack of correlation between praziquantel-induced intra-worm calcium influx and parasite death. Exp Parasitol 2008,119(3),332-335","journal-title":"Exp Parasitol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1006\/scdb.1999.0324","volume":"10","author":"Agata K.","year":"1999","unstructured":"Agata K.; Watanabe K.; Molecular and cellular aspects of planarian regeneration. Semin Cell Dev Biol 1999,10(4),377-383","journal-title":"Semin Cell Dev Biol"},{"key":"ref=108","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000464","volume":"3","author":"Nogi T.","year":"2009","unstructured":"Nogi T.; Zhang D.; Chan J.D.; Marchant J.S.; A novel biological activity of praziquantel requiring voltage-operated Ca channel beta subunits: subversion of flatworm regenerative polarity. PLoS Negl Trop Dis 2009,3(6)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"15983","DOI":"10.1523\/JNEUROSCI.3029-11.2011","volume":"31","author":"Zhang D.","year":"2011","unstructured":"Zhang D.; Chan J.D.; Nogi T.; Marchant J.S.; Opposing roles of voltage-gated Ca channels in neuronal control of regenerative patterning. J Neurosci 2011,31(44),15983-15995","journal-title":"J Neurosci"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1126\/science.1178712","volume":"326","author":"Rink J.C.","year":"2009","unstructured":"Rink J.C.; Gurley K.A.; Elliott S.A.; S\u00e1nchez Alvarado A.; Planarian Hh signaling regulates regeneration polarity and links Hh pathway evolution to cilia. Science 2009,326(5958),1406-1410","journal-title":"Science"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.parint.2012.12.001","volume":"62","author":"Chan J.D.","year":"2013","unstructured":"Chan J.D.; Zarowiecki M.; Marchant J.S.; Ca channels and praziquantel: a view from the free world. Parasitol Int 2013,62(6),619-628","journal-title":"Parasitol Int"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1139\/y80-044","volume":"58","author":"Church J.","year":"1980","unstructured":"Church J.; Zsot\u00e9r T.T.; Calcium antagonistic drugs. Mechanism of action. Can J Physiol Pharmacol 1980,58(3),254-264","journal-title":"Can J Physiol Pharmacol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1469-7793.2001.0609e.x","volume":"532","author":"Curtis T.M.","year":"2001","unstructured":"Curtis T.M.; Scholfield C.N.; Nifedipine blocks Ca store refilling through a pathway not involving L-type Ca channels in rabbit arteriolar smooth muscle. J Physiol 2001,532(Pt 3),609-623","journal-title":"J Physiol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1023\/A:1023632419813","volume":"23","author":"Triggle D.J.","year":"2003","unstructured":"Triggle D.J.; 1,4-Dihydropyridines as calcium channel ligands and privileged structures. Cell Mol Neurobiol 2003,23(3),293-303","journal-title":"Cell Mol Neurobiol"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1590\/0074-0276108052013011","volume":"108","author":"Silva-Moraes V.","year":"2013","unstructured":"Silva-Moraes V.; Couto F.F.; Vasconcelos M.M.; Ara\u00fajo N.; Coelho P.M.; Katz N.; Grenfell R.F.; Antischistosomal activity of a calcium channel antagonist on schistosomula and adult Schistosoma mansoni worms. Mem Inst Oswaldo Cruz 2013,108(5),600-604","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref=116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000790","volume":"4","author":"Novozhilova E.","year":"2010","unstructured":"Novozhilova E.; Kimber M.J.; Qian H.; McVeigh P.; Robertson A.P.; Zamanian M.; Maule A.G.; Day T.A.; FMRFamide-like peptides (FLPs) enhance voltage-gated calcium currents to elicit muscle contraction in the human parasite Schistosoma mansoni. PLoS Negl Trop Dis 2010,4(8)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/BF00931079","volume":"76","author":"Katsumata T.","year":"1989","unstructured":"Katsumata T.; Kohno S.; Yamaguchi K.; Hara K.; Aoki Y.; Hatching of Schistosoma mansoni eggs is a Ca\/calmodulin-dependent process. Parasitol Res 1989,76(1),90-91","journal-title":"Parasitol Res"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/jez.1402390105","volume":"239","author":"Senft A.","year":"1986","unstructured":"Senft A.; Gibler W.; Guterman J.; Influence of calcium\u2010 perturbing agents on schistosomes: Comparison of effects of praziquantel and verapamil on worm tegument. J Exp Zool Part A Ecol Genet Physiol 1986,239(1),25-36","journal-title":"J Exp Zool Part A Ecol Genet Physiol"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1645\/GE-2586.1","volume":"97","author":"Taft A.S.","year":"2011","unstructured":"Taft A.S.; Yoshino T.P.; Cloning and functional characterization of two calmodulin genes during larval development in the parasitic flatworm Schistosoma mansoni. J Parasitol 2011,97(1),72-81","journal-title":"J Parasitol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"R1051","DOI":"10.1152\/ajpregu.1986.251.6.R1051","volume":"251","author":"Thompson D.P.","year":"1986","unstructured":"Thompson D.P.; Chen G.Z.; Sample A.K.; Semeyn D.R.; Bennett J.L.; Calmodulin: biochemical, physiological, and morphological effects on Schistosoma mansoni. Am J Physiol 1986,251(6 Pt 2),R1051-R1058","journal-title":"Am J Physiol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1085\/jgp.201311153","volume":"143","author":"Ben-Johny M.","year":"2014","unstructured":"Ben-Johny M.; Yue D.T.; Calmodulin regulation (calmodulation) of voltage-gated calcium channels. J Gen Physiol 2014,143(6),679-692","journal-title":"J Gen Physiol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nature08160","volume":"460","author":"Berriman M.","year":"2009","unstructured":"Berriman M.; Haas B.J.; LoVerde P.T.; Wilson R.A.; Dillon G.P.; Cerqueira G.C.; Mashiyama S.T.; Al-Lazikani B.; Andrade L.F.; Ashton P.D.; Aslett M.A.; Bartholomeu D.C.; Blandin G.; Caffrey C.R.; Coghlan A.; Coulson R.; Day T.A.; Delcher A.; DeMarco R.; Djikeng A.; Eyre T.; Gamble J.A.; Ghedin E.; Gu Y.; Hertz-Fowler C.; Hirai H.; Hirai Y.; Houston R.; Ivens A.; Johnston D.A.; Lacerda D.; Macedo C.D.; McVeigh P.; Ning Z.; Oliveira G.; Overington J.P.; Parkhill J.; Pertea M.; Pierce R.J.; Protasio A.V.; Quail M.A.; Rajandream M.A.; Rogers J.; Sajid M.; Salzberg S.L.; Stanke M.; Tivey A.R.; White O.; Williams D.L.; Wortman J.; Wu W.; Zamanian M.; Zerlotini A.; Fraser-Liggett C.M.; Barrell B.G.; El-Sayed N.M.; The genome of the blood fluke Schistosoma mansoni. Nature 2009,460(7253),352-358","journal-title":"Nature"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1017\/S0031182001008691","volume":"123","author":"Kohn A.B.","year":"2001","unstructured":"Kohn A.B.; Lea J.; Roberts-Misterly J.M.; Anderson P.A.; Greenberg R.M.; Structure of three high voltage-activated calcium channel alpha1 subunits from Schistosoma mansoni. Parasitology 2001,123(Pt 5),489-497","journal-title":"Parasitology"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1042\/BST20150270","volume":"44","author":"Thomas C.M.","year":"2016","unstructured":"Thomas C.M.; Timson D.J.; A mysterious family of calcium-binding proteins from parasitic worms. Biochem Soc Trans 2016,44(4),1005-1010","journal-title":"Biochem Soc Trans"},{"key":"ref=125","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001593","volume":"6","author":"Fitzsimmons C.M.","year":"2012","unstructured":"Fitzsimmons C.M.; Jones F.M.; Stearn A.; Chalmers I.W.; Hoffmann K.F.; Wawrzyniak J.; Wilson S.; Kabatereine N.B.; Dunne D.W.; The Schistosoma mansoni tegumental-allergen-like (TAL) protein family: influence of developmental expression on human IgE responses. PLoS Negl Trop Dis 2012,6(4)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.biochi.2014.10.015","volume":"108","author":"Thomas C.M.","year":"2015","unstructured":"Thomas C.M.; Fitzsimmons C.M.; Dunne D.W.; Timson D.J.; Comparative biochemical analysis of three members of the Schistosoma mansoni TAL family: differences in ion and drug binding properties. Biochimie 2015,108,40-47","journal-title":"Biochimie"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"14509","DOI":"10.1074\/jbc.272.23.14509","volume":"272","author":"Hoffmann K.F.","year":"1997","unstructured":"Hoffmann K.F.; Strand M.; Molecular characterization of a 20.8-kDa Schistosoma mansoni antigen. Sequence similarity to tegumental associated antigens and dynein light chains. J Biol Chem 1997,272(23),14509-14515","journal-title":"J Biol Chem"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.molbiopara.2018.02.002","volume":"221","author":"Carson J.","year":"2018","unstructured":"Carson J.; Thomas C.M.; McGinty A.; Takata G.; Timson D.J.; The tegumental allergen-like proteins of Schistosoma mansoni: a biochemical study of SmTAL4-TAL13. Mol Biochem Parasitol 2018,221,14-22","journal-title":"Mol Biochem Parasitol"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s40588-014-0007-6","volume":"1","author":"Greenberg R.M.","year":"2014","unstructured":"Greenberg R.M.; Ion channels and drug transporters as targets for anthelmintics. Curr Clin Microbiol Rep 2014,1(3-4),51-60","journal-title":"Curr Clin Microbiol Rep"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.exppara.2006.09.017","volume":"115","author":"Pica-Mattoccia L.","year":"2007","unstructured":"Pica-Mattoccia L.; Valle C.; Basso A.; Troiani A.R.; Vigorosi F.; Liberti P.; Festucci A.; Cioli D.; Cytochalasin D abolishes the schistosomicidal activity of praziquantel. Exp Parasitol 2007,115(4),344-351","journal-title":"Exp Parasitol"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.ijantimicag.2006.12.018","volume":"29","author":"Tallima H.","year":"2007","unstructured":"Tallima H.; El Ridi R.; Praziquantel binds Schistosoma mansoni adult worm actin. Int J Antimicrob Agents 2007,29(5),570-575","journal-title":"Int J Antimicrob Agents"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ijantimicag.2007.05.004","volume":"30","author":"Troiani A.R.","year":"2007","unstructured":"Troiani A.R.; Pica-Mattoccia L.; Valle C.; Cioli D.; Mignogna G.; Ronketti F.; Todd M.; Is actin the praziquantel receptor? Int J Antimicrob Agents 2007,30(3),280-281","journal-title":"Int J Antimicrob Agents"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1017\/S0031182007002600","volume":"134","author":"Angelucci F.","year":"2007","unstructured":"Angelucci F.; Basso A.; Bellelli A.; Brunori M.; Pica Mattoccia L.; Valle C.; The anti-schistosomal drug praziquantel is an adenosine antagonist. Parasitology 2007,134(Pt 9),1215-1221","journal-title":"Parasitology"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1128\/AAC.01222-08","volume":"53","author":"Gnanasekar M.","year":"2009","unstructured":"Gnanasekar M.; Salunkhe A.M.; Mallia A.K.; He Y.X.; Kalyanasundaram R.; Praziquantel affects the regulatory myosin light chain of Schistosoma mansoni. Antimicrob Agents Chemother 2009,53(3),1054-1060","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1126\/science.8316857","volume":"261","author":"Rayment I.","year":"1993","unstructured":"Rayment I.; Rypniewski W.R.; Schmidt-B\u00e4se K.; Smith R.; Tomchick D.R.; Benning M.M.; Winkelmann D.A.; Wesenberg G.; Holden H.M.; Three-dimensional structure of myosin subfragment-1: a molecular motor. Science 1993,261(5117),50-58","journal-title":"Science"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0300-9084(81)80115-0","volume":"63","author":"Scholey J.M.","year":"1981","unstructured":"Scholey J.M.; Taylor K.A.; Kendrick-Jones J.; The role of myosin light chains in regulating actin-myosin interaction. Biochimie 1981,63(4),255-271","journal-title":"Biochimie"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1139\/y94-200","volume":"72","author":"Zhang Y.","year":"1994","unstructured":"Zhang Y.; Moreland S.; Moreland R.S.; Regulation of vascular smooth muscle contraction: myosin light chain phosphorylation dependent and independent pathways. Can J Physiol Pharmacol 1994,72(11),1386-1391","journal-title":"Can J Physiol Pharmacol"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1006\/jmbi.1994.0061","volume":"246","author":"McTigue M.A.","year":"1995","unstructured":"McTigue M.A.; Williams D.R.; Tainer J.A.; Crystal structures of a schistosomal drug and vaccine target: glutathione S-transferase from Schistosoma japonica and its complex with the leading antischistosomal drug praziquantel. J Mol Biol 1995,246(1),21-27","journal-title":"J Mol Biol"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1006\/expr.1997.4231","volume":"87","author":"Milhon J.L.","year":"1997","unstructured":"Milhon J.L.; Thiboldeaux R.L.; Glowac K.; Tracy J.W.; \n                        Schistosoma japonicum GSH S-transferase Sj26 is not the molecular target of praziquantel action. Exp Parasitol 1997,87(3),268-274","journal-title":"Exp Parasitol"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1038\/s41467-017-02084-0","volume":"8","author":"Chan J.D.","year":"2017","unstructured":"Chan J.D.; Cupit P.M.; Gunaratne G.S.; McCorvy J.D.; Yang Y.; Stoltz K.; Webb T.R.; Dosa P.I.; Roth B.L.; Abagyan R.; Cunningham C.; Marchant J.S.; The anthelmintic praziquantel is a human serotoninergic G-protein-coupled receptor ligand. Nat Commun 2017,8(1),1910","journal-title":"Nat Commun"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000076942","volume":"71","author":"Calama E.","year":"2004","unstructured":"Calama E.; Mor\u00e1n A.; Ortiz de Urbina A.V.; Mart\u00edn M.L.; San Rom\u00e1n L.; Vasoconstrictor responses to 5-hydroxytryptamine in the autoperfused hindquarters of spontaneously hypertensive rats. Pharmacology 2004,71(2),66-72","journal-title":"Pharmacology"},{"key":"ref=142","first-page":"507","volume":"65","author":"Doenhoff M.J.","year":"1988","unstructured":"Doenhoff M.J.; Modha J.; Lambertucci J.R.; Anti-schistosome chemotherapy enhanced by antibodies specific for a parasite esterase. Immunology 1988,65(4),507-510","journal-title":"Immunology"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1006\/expr.1995.1030","volume":"80","author":"Hall T.M.","year":"1995","unstructured":"Hall T.M.; Joseph G.T.; Strand M.; \n                        Schistosoma mansoni: molecular cloning and sequencing of the 200-kDa chemotherapeutic target antigen. Exp Parasitol 1995,80(2),242-249","journal-title":"Exp Parasitol"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"5141","DOI":"10.1016\/j.vaccine.2012.05.056","volume":"30","author":"Zhang Z.","year":"2012","unstructured":"Zhang Z.; Xu H.; Gan W.; Zeng S.; Hu X.; \n                        Schistosoma japonicum calcium-binding tegumental protein SjTP22.4 immunization confers praziquantel schistosomulumicide and antifecundity effect in mice. Vaccine 2012,30(34),5141-5150","journal-title":"Vaccine"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4269\/ajtmh.1994.51.83","volume":"51","author":"Fallon P.G.","year":"1994","unstructured":"Fallon P.G.; Doenhoff M.J.; Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am J Trop Med Hyg 1994,51(1),83-88","journal-title":"Am J Trop Med Hyg"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.yexmp.2007.01.009","volume":"82","author":"Brennan G.P.","year":"2007","unstructured":"Brennan G.P.; Fairweather I.; Trudgett A.; Hoey E.; McCoy; McConville, M.; Meaney, M.; Robinson, M.; McFerran, N.; Ryan, L.; Lanusse, C.; Mottier, L.; Alvarez, L.; Solana, H.; Virkel, G.; Brophy, P.M. Understanding triclabendazole resistance. Exp Mol Pathol 2007,82(2),104-109","journal-title":"Exp Mol Pathol"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.molbiopara.2012.08.008","volume":"186","author":"Wilkinson R.","year":"2012","unstructured":"Wilkinson R.; Law C.J.; Hoey E.M.; Fairweather I.; Brennan G.P.; Trudgett A.; An amino acid substitution in Fasciola hepatica P-glycoprotein from triclabendazole-resistant and triclabendazole-susceptible populations. Mol Biochem Parasitol 2012,186(1),69-72","journal-title":"Mol Biochem Parasitol"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1016\/j.lfs.2006.08.010","volume":"79","author":"Jabbar A.","year":"2006","unstructured":"Jabbar A.; Iqbal Z.; Kerboeuf D.; Muhammad G.; Khan M.N.; Afaq M.; Anthelmintic resistance: the state of play revisited. Life Sci 2006,79(26),2413-2431","journal-title":"Life Sci"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1017\/S0031182013000231","volume":"140","author":"Greenberg R.M.","year":"2013","unstructured":"Greenberg R.M.; New approaches for understanding mechanisms of drug resistance in schistosomes. Parasitology 2013,140(12),1534-1546","journal-title":"Parasitology"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1017\/S0022149X00015790","volume":"71","author":"Southgate V.R.","year":"1997","unstructured":"Southgate V.R.; Schistosomiasis in the Senegal River Basin: before and after the construction of the dams at Diama, Senegal and Manantali, Mali and future prospects. J Helminthol 1997,71(2),125-132","journal-title":"J Helminthol"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1086\/517273","volume":"176","author":"Stelma F.F.","year":"1997","unstructured":"Stelma F.F.; Sall S.; Daff B.; Sow S.; Niang M.; Gryseels B.; Oxamniquine cures Schistosoma mansoni infection in a focus in which cure rates with praziquantel are unusually low. J Infect Dis 1997,176(1),304-307","journal-title":"J Infect Dis"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4269\/ajtmh.1995.53.167","volume":"53","author":"Stelma F.F.","year":"1995","unstructured":"Stelma F.F.; Talla I.; Sow S.; Kongs A.; Niang M.; Polman K.; Deelder A.M.; Gryseels B.; Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni. Am J Trop Med Hyg 1995,53(2),167-170","journal-title":"Am J Trop Med Hyg"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1006\/expr.1997.4149","volume":"86","author":"Fallon P.G.","year":"1997","unstructured":"Fallon P.G.; Mubarak J.S.; Fookes R.E.; Niang M.; Butterworth A.E.; Sturrock R.F.; Doenhoff M.J.; \n                        Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates. Exp Parasitol 1997,86(1),29-36","journal-title":"Exp Parasitol"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"214","DOI":"10.4269\/ajtmh.1996.55.214","volume":"55","author":"Ismail M.","year":"1996","unstructured":"Ismail M.; Metwally A.; Farghaly A.; Bruce J.; Tao L.F.; Bennett J.L.; Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. Am J Trop Med Hyg 1996,55(2),214-218","journal-title":"Am J Trop Med Hyg"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"932","DOI":"10.4269\/ajtmh.1999.60.932","volume":"60","author":"Ismail M.","year":"1999","unstructured":"Ismail M.; Botros S.; Metwally A.; William S.; Farghally A.; Tao L.F.; Day T.A.; Bennett J.L.; Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Am J Trop Med Hyg 1999,60(6),932-935","journal-title":"Am J Trop Med Hyg"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S0020-7519(01)00215-6","volume":"31","author":"William S.","year":"2001","unstructured":"William S.; Sabra A.; Ramzy F.; Mousa M.; Demerdash Z.; Bennett J.L.; Day T.A.; Botros S.; Stability and reproductive fitness of Schistosoma mansoni isolates with decreased sensitivity to praziquantel. Int J Parasitol 2001,31(10),1093-1100","journal-title":"Int J Parasitol"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1645\/GE-1297.1","volume":"94","author":"Sabra A.N.","year":"2008","unstructured":"Sabra A.N.; Botros S.S.; Response of Schistosoma mansoni isolates having different drug sensitivity to praziquantel over several life cycle passages with and without therapeutic pressure. J Parasitol 2008,94(2),537-541","journal-title":"J Parasitol"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1006\/expr.1993.1104","volume":"77","author":"Pica-Mattoccia L.","year":"1993","unstructured":"Pica-Mattoccia L.; Dias L.C.; Moroni R.; Cioli D.; \n                        Schistosoma mansoni: genetic complementation analysis shows that two independent hycanthone\/oxamniquine-resistant strains are mutated in the same gene. Exp Parasitol 1993,77(4),445-449","journal-title":"Exp Parasitol"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.actatropica.2009.01.012","volume":"111","author":"Pica-Mattoccia L.","year":"2009","unstructured":"Pica-Mattoccia L.; Doenhoff M.J.; Valle C.; Basso A.; Troiani A.R.; Liberti P.; Festucci A.; Guidi A.; Cioli D.; Genetic analysis of decreased praziquantel sensitivity in a laboratory strain of Schistosoma mansoni. Acta Trop 2009,111(1),82-85","journal-title":"Acta Trop"},{"key":"ref=160","first-page":"274","volume":"34","author":"Liang Y.S.","year":"2003","unstructured":"Liang Y.S.; Dai J.R.; Zhu Y.C.; Coles G.C.; Doenhoff M.J.; Genetic analysis of praziquantel resistance in Schistosoma mansoni. Southeast Asian J Trop Med Public Health 2003,34(2),274-280","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.molbiopara.2012.09.006","volume":"186","author":"Hines-Kay J.","year":"2012","unstructured":"Hines-Kay J.; Cupit P.M.; Sanchez M.C.; Rosenberg G.H.; Hanelt B.; Cunningham C.; Transcriptional analysis of Schistosoma mansoni treated with praziquantel in vitro. Mol Biochem Parasitol 2012,186(2),87-94","journal-title":"Mol Biochem Parasitol"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1016\/j.bmcl.2007.05.063","volume":"17","author":"Ronketti F.","year":"2007","unstructured":"Ronketti F.; Ramana A.V.; Chao-Ming X.; Pica-Mattoccia L.; Cioli D.; Todd M.H.; Praziquantel derivatives I: Modification of the aromatic ring. Bioorg Med Chem Lett 2007,17(15),4154-4157","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.bmcl.2011.12.133","volume":"22","author":"Duan W.W.","year":"2012","unstructured":"Duan W.W.; Qiu S.J.; Zhao Y.; Sun H.; Qiao C.; Xia C.M.; Praziquantel derivatives exhibit activity against both juvenile and adult Schistosoma japonicum. Bioorg Med Chem Lett 2012,22(4),1587-1590","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=164","first-page":"105","volume":"8","author":"Utzinger J.","year":"2007","unstructured":"Utzinger J.; Xiao S.H.; Tanner M.; Keiser J.; Artemisinins for schistosomiasis and beyond. Currunt opinion in investigational drugs; London, England 2007,8(2),105-116","journal-title":"Currunt opinion in investigational drugs; London, England"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.2174\/0929867013371581","volume":"8","author":"Utzinger J.","year":"2001","unstructured":"Utzinger J.; Xiao S.; Keiser J.; Chen M.; Zheng J.; Tanner M.; Current progress in the development and use of artemether for chemoprophylaxis of major human schistosome parasites. Curr Med Chem 2001,8(15),1841-1860","journal-title":"Curr Med Chem"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1365-2958.1995.tb02404.x","volume":"16","author":"Fr\u00e8re J.M.","year":"1995","unstructured":"Fr\u00e8re J.M.; Beta-lactamases and bacterial resistance to antibiotics. Mol Microbiol 1995,16(3),385-395","journal-title":"Mol Microbiol"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1093\/sysbio\/42.4.476","volume":"42","author":"Cannatella D.C.","year":"1993","unstructured":"Cannatella D.C.; De Sa R.O.; \n                        Xenopus laevis as a model organism. Syst Biol 1993,42(4),476-507","journal-title":"Syst Biol"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1017\/S0031182013000425","volume":"141","author":"Norcliffe J.L.","year":"2014","unstructured":"Norcliffe J.L.; Alvarez-Ruiz E.; Martin-Plaza J.J.; Steel P.G.; Denny P.W.; The utility of yeast as a tool for cell-based, target-directed high-throughput screening. Parasitology 2014,141(1),8-16","journal-title":"Parasitology"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"E5660","DOI":"10.1073\/pnas.1513439112","volume":"112","author":"Sulbar\u00e1n G.","year":"2015","unstructured":"Sulbar\u00e1n G.; Alamo L.; Pinto A.; M\u00e1rquez G.; M\u00e9ndez F.; Padr\u00f3n R.; Craig R.; An invertebrate smooth muscle with striated muscle myosin filaments. Proc Natl Acad Sci USA 2015,112(42),E5660-E5668","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/35036035","volume":"1","author":"Berridge M.J.","year":"2000","unstructured":"Berridge M.J.; Lipp P.; Bootman M.D.; The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 2000,1(1),11-21","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ijpddr.2011.09.003","volume":"1","author":"Wolstenholme A.J.","year":"2011","unstructured":"Wolstenholme A.J.; Ion channels and receptor as targets for the control of parasitic nematodes. Int J Parasitol Drugs Drug Resist 2011,1(1),2-13","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/nrc749","volume":"2","author":"Hurley L.H.","year":"2002","unstructured":"Hurley L.H.; DNA and its associated processes as targets for cancer therapy. Nat Rev Cancer 2002,2(3),188-200","journal-title":"Nat Rev Cancer"},{"key":"ref=173","first-page":"197","volume":"38","author":"Davis A.","year":"1968","unstructured":"Davis A.; Comparative trials of antimonial drugs in urinary schistosomiasis. Bull World Health Organ 1968,38(2),197-227","journal-title":"Bull World Health Organ"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1476-5381.1957.tb00114.x","volume":"12","author":"Bueding E.","year":"1957","unstructured":"Bueding E.; Mansour J.M.; The relationship between inhibition of phosphofructokinase activity and the mode of action of trivalent organic antimonials on Schistosoma mansoni. Br J Pharmacol Chemother 1957,12(2),159-165","journal-title":"Br J Pharmacol Chemother"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0166-6851(96)02702-8","volume":"81","author":"Su J.G.","year":"1996","unstructured":"Su J.G.; Mansour J.M.; Mansour T.E.; Purification, kinetics and inhibition by antimonials of recombinant phosphofructokinase from Schistosoma mansoni. Mol Biochem Parasitol 1996,81(2),171-178","journal-title":"Mol Biochem Parasitol"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0166-6851(82)90016-0","volume":"5","author":"Schulman M.D.","year":"1982","unstructured":"Schulman M.D.; Ostlind D.A.; Valentino D.; Mechanism of action of MK-401 against Fasciola hepatica: inhibition of phosphoglycerate kinase. Mol Biochem Parasitol 1982,5(3),133-145","journal-title":"Mol Biochem Parasitol"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/0014-4894(80)90117-4","volume":"49","author":"Schulman M.D.","year":"1980","unstructured":"Schulman M.D.; Valentino D.; \n                        Fasciola hepatica: effect of 4-amino-6-trichloroethenyl-1,3-benzenedisulfonamide on glycolysis in vitro. Exp Parasitol 1980,49(2),206-215","journal-title":"Exp Parasitol"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0166-6851(82)90039-1","volume":"5","author":"Schulman M.D.","year":"1982","unstructured":"Schulman M.D.; Valentino D.; Purification, characterization and inhibition by MK-401 of Fasciola hepatica phosphoglyceromutase. Mol Biochem Parasitol 1982,5(5),321-332","journal-title":"Mol Biochem Parasitol"},{"key":"ref=179","first-page":"171","volume":"37","author":"Mossallam S.F.","year":"2007","unstructured":"Mossallam S.F.; Ali S.M.; El Zawawy L.A.; Said D.E.; The efficacy of antihelminthic compound; Clorsulon against experimental Schistosoma mansoni infection. J Egypt Soc Parasitol 2007,37(1),171-188","journal-title":"J Egypt Soc Parasitol"},{"key":"ref=180","first-page":"797","volume":"70","author":"Shames N.","year":"2000","unstructured":"Shames N.; Agrawal M.; Rao K.; Chemotherapeutic efficacy of praziquantel and closantel in experimental porcine schistosomiasis. Indian J Anim Sci 2000,70(8),797-800","journal-title":"Indian J Anim Sci"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"280","DOI":"10.2174\/1389203717999160226180733","volume":"17","author":"Timson D.J.","year":"2016","unstructured":"Timson D.J.; Metabolic enzymes of helminth parasites: potential as drug targets. Curr Protein Pept Sci 2016,17(3),280-295","journal-title":"Curr Protein Pept Sci"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/165702","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T11:23:26Z","timestamp":1585394606000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/165702\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,16]]},"references-count":181,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,3,16]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867325666180926145537","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,16]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2017-12-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}